Government regulations affect drug development, often prolonging the process, but they ensure safety and efficacy to protect ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, CDMOs Bora Pharmaceuticals and Corealis Pharma understand that oral solid ...

Pharmaceutical companies often choose not to advance drug candidates for business reasons, rather than because of safety or efficacy concerns. These compounds could still help some people, so biotech ...